0001209191-23-022465.txt : 20230404
0001209191-23-022465.hdr.sgml : 20230404
20230404083520
ACCESSION NUMBER: 0001209191-23-022465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230403
FILED AS OF DATE: 20230404
DATE AS OF CHANGE: 20230404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Winton Matthew
CENTRAL INDEX KEY: 0001971400
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39397
FILM NUMBER: 23795194
MAIL ADDRESS:
STREET 1: C/O INOZYME PHARMA, INC.
STREET 2: 321 SUMMER STREET, SUITE 400
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inozyme Pharma, Inc.
CENTRAL INDEX KEY: 0001693011
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475129768
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 SUMMER STREET
STREET 2: SUITE 400
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-330-4340
MAIL ADDRESS:
STREET 1: 321 SUMMER STREET
STREET 2: SUITE 400
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Inozyme Pharma, LLC
DATE OF NAME CHANGE: 20161222
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-03
0
0001693011
Inozyme Pharma, Inc.
INZY
0001971400
Winton Matthew
C/O INOZYME PHARMA, INC.
321 SUMMER STREET, SUITE 400
BOSTON
MA
02210
0
1
0
0
COO
0
Stock option (right to buy)
5.39
2023-04-03
4
A
0
250000
0.00
A
2033-04-02
Common Stock
250000
250000
D
The option was granted on April 3, 2023 and is scheduled to vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the option are scheduled to vest in equal monthly installments over the following three years until the fourth anniversary of the grant date.
/s/ Matthew Winton
2023-04-04